Ashwagandha can be effective COVID-19 preventive drug

The government has also initiated a study on whether Ashwagandha can be an alternative to anti-malarial drug Hydroxychloroquine (HCQ) as a potential COVID-19 preventive.

Ayurvedic herb Ashwagandha can be an effective therapeutic and preventive drug against the COVID-19 infection, a collaborative research by IIT-Delhi and Japan’s National Institute of Advanced Industrial Science and Technology (AIST) has found. The natural compounds from Ashwagandha and Propolis have the potential to be an effective novel coronavirus preventive drug, according to the research team.

“The researchers targeted the main SARS-CoV-2’s enzyme for splitting proteins, known as the main protease (Mpro), that plays a key role in mediating viral replication. This is an attractive drug target for this virus, and as humans don’t naturally have this enzyme, compounds that target Mpro are likely to have low toxicity,” said D Sundar, head of the Delhi Indian Institute of Technology’s Biotechnology department.

For Full article, buy Ayurved Sutra Vol. 07 Issue 11

Related posts:

Ashwagandha to help in fighting Corona,claims IIT research Curious case of Coronil : Patanjali can sell its drug but not as ‘cure’ for Covid-19 Health and AYUSH Ministers formally launch inter-disciplinary studies involving AYUSH interventions for COVID 19 situation CSIR-IMTECH to have biorepository of COVID-19 samples Time is a critical factor in plasma collection post COVID-19 recovery – Study